Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid, ketorolac, and normal saline injections for lateral epicondylitis
IRCT20250729066680N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of methylprednisolone, ketorolac and Normal Saline-Benha University in Lateral Epicondylitis (LET) (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Post-injection pain intensity. Started Sep 2025; status: completed.
02
Drugs
methylprednisoloneketorolacNormal Saline-Benha University
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on IRCT20250729066680N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250729066680N1.